Following AbbVie’s steps, Teva leaves PhRMA

About two months after AbbVie departed from the Pharmaceutical Research and Manufacturers of America, Teva Pharmaceuticals followed suit.

Advertisement

“Teva has decided not to renew its membership with PhRMA in 2023,” PhRMA spokesperson Brian Newell told Becker’s. “Our organization will remain focused on fighting for solutions that lower costs for patients at the pharmacy and protect the development of new cures and treatments.”

In response to questions about its exit, a Teva spokesperson told Becker’s the Israel-based company “annually review[s] effectiveness and value of engagements, consultants and memberships to ensure our investments are properly seated.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.